Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Dr. David Liu, pictured with former lab members Holly Rees ...
X-linked chronic granulomatous disease (X-CGD) is a rare genetic disorder characterized by high susceptibility to infections that results from genetic mutations in the cytochrome b-245 beta chain ...
Recent biomedical news headlines have exposed the deadly lack of ethics in research involving human embryos. Dr. Dieter Egli, a Columbia University developmental cell biologist, claims his team ...
The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing editing ...
Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children's Research Hospital. Significant amounts of time and resources ...
Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...
Point mutations in the lamin A (LMNA) gene cause several human diseases, ranging from congenital muscular dystrophy to premature aging, collectively known as laminopathies, which affect skeletal ...
Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study. Researchers from The Jackson Laboratory (JAX; ME, USA) have used gene ...
Cambridge, U.K.-based Broken String Biosciences launched BaseMap™ ABE, built on the company’s INDUCE-seq ® technology, to support adenine base editing (ABE) applications. Base editing is gaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results